Related Experiment Video
Updated: Apr 29, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Prognostic value of access site and nonaccess site bleeding after percutaneous coronary intervention: a cohort study
Wouter J Kikkert1, Ronak Delewi1, Dagmar M Ouweneel1
1Academic Medical Center-University of Amsterdam, Amsterdam, the Netherlands.
Insights
Access site bleeding (ASB) after ST-segment elevation myocardial infarction (STEMI) does not increase mortality risk. However, non-access site bleeding (non-ASB) is linked to higher risks of death and stent thrombosis.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Outcomes Research
Background:
- The prognostic implications of access site bleeding (ASB) following ST-segment elevation myocardial infarction (STEMI) remain a subject of clinical debate.
- Understanding complications after primary percutaneous coronary intervention (PCI) is crucial for patient management.
Purpose of the Study:
- To evaluate the prognostic significance of access site bleeding (ASB) versus non-access site bleeding (non-ASB) for adverse ischemic events and mortality in STEMI patients.
- To clarify the association between bleeding complications and long-term outcomes after primary PCI.
Main Methods:
- A cohort of 2,002 STEMI patients undergoing primary PCI was analyzed for 1-year outcomes.
- Outcomes assessed included mortality, recurrent myocardial infarction (MI), stent thrombosis, and stroke.
- A meta-analysis of existing studies on ASB and non-ASB in PCI patients was also conducted.
Main Results:
- ASB occurred in 6.3% of patients and was not significantly associated with increased 1-year mortality, recurrent MI, stent thrombosis, or stroke.
- Non-ASB was independently linked to a higher risk of 1-year mortality (HR: 2.77) and stent thrombosis (HR: 3.10).
- The meta-analysis of nearly 500,000 patients confirmed that non-ASB is associated with a greater adjusted risk of subsequent 1-year mortality compared to ASB.
Conclusions:
- In STEMI patients treated with primary PCI, ASB does not appear to significantly impact 1-year clinical outcomes.
- Non-ASB is a significant independent predictor of 1-year mortality and stent thrombosis.
- The findings suggest that non-ASB, rather than ASB, carries a greater prognostic burden for mortality after PCI in STEMI.
Objectives:
This study sought to investigate the prognostic value of access site bleeding (ASB) and non-ASB for recurrent ischemic outcomes and mortality in patients with ST-segment elevation myocardial infarction (STEMI).
Background:
The prognostic value of ASB-related complications after STEMI is subject to debate.
Methods:
The prognostic value of ASB and non-ASB for 1-year mortality, recurrent myocardial infarction (MI), stent thrombosis, and stroke was investigated in 2,002 STEMI patients undergoing primary percutaneous coronary intervention. In addition, we performed a meta-analysis of studies investigating the prognostic value of ASB and non-ASB in patients undergoing percutaneous coronary intervention.
Results:
Seventy-four patients (3.7%) were treated by radial access. ASB developed in 124 patients (6.3%) and non-ASB developed in 102 (5.2%). By multivariable analysis, ASB was not associated with a higher risk of 1-year mortality (hazard ratio [HR]: 1.03; p = 0.89), recurrent MI (HR: 1.16; p = 0.64), stent thrombosis (HR: 0.55; p = 0.42), or stroke (HR: 0.47; p = 0.31). Non-ASB was independently associated with 1-year mortality (HR: 2.77; p < 0.001) and stent thrombosis (HR: 3.10; p = 0.021), but not with recurrent MI and stroke. In a meta-analysis including 495,630 patients, non-ASB was associated with a greater adjusted risk of subsequent 1-year mortality than ASB (HR: 1.66; 95% CI: 1.56 to 1.76 and HR: 1.21; 95% CI: 1.11 to 1.31).
Conclusions:
In STEMI, ASB was not significantly associated with 1-year clinical outcomes, whereas non-ASB was significantly associated with 1-year mortality and stent thrombosis. These results taken together with those of previous studies indicate a greater risk of subsequent mortality in patients with non-ASB.
More Related Videos
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
06:04Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Peripheral Artery Disease V: Postoperative Nursing Management